Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates

[url="]Spruce Biosciences, Inc.[/url] (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neur